Connection

CHRIS AMOS to Risk Factors

This is a "connection" page, showing publications CHRIS AMOS has written about Risk Factors.
Connection Strength

2.561
  1. Effects of smoking behavior on lung metastasis in the All of Us Research Program. Sci Rep. 2025 Apr 01; 15(1):11114.
    View in: PubMed
    Score: 0.083
  2. A comprehensive analysis of lung cancer highlighting epidemiological factors and psychiatric comorbidities from the All of Us Research Program. Sci Rep. 2023 07 05; 13(1):10852.
    View in: PubMed
    Score: 0.073
  3. Smoking Status and Factors associated with COVID-19 In-Hospital Mortality among US Veterans. Nicotine Tob Res. 2022 03 26; 24(5):785-793.
    View in: PubMed
    Score: 0.067
  4. Shared genomic architecture between COVID-19 severity and numerous clinical and physiologic parameters revealed by LD score regression analysis. Sci Rep. 2022 02 03; 12(1):1891.
    View in: PubMed
    Score: 0.066
  5. A Novel Pathway-Based Approach Improves Lung Cancer Risk Prediction Using Germline Genetic Variations. Cancer Epidemiol Biomarkers Prev. 2016 08; 25(8):1208-15.
    View in: PubMed
    Score: 0.045
  6. Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiol Biomarkers Prev. 2013 Feb; 22(2):251-60.
    View in: PubMed
    Score: 0.035
  7. Genetic association analysis of complex diseases incorporating intermediate phenotype information. PLoS One. 2012; 7(10):e46612.
    View in: PubMed
    Score: 0.035
  8. Multistage analysis of variants in the inflammation pathway and lung cancer risk in smokers. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1213-21.
    View in: PubMed
    Score: 0.034
  9. A case-control study of a sex-specific association between a 15q25 variant and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2603-9.
    View in: PubMed
    Score: 0.033
  10. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis. 2011 Oct; 32(10):1493-9.
    View in: PubMed
    Score: 0.032
  11. Ordered subset analysis identifies loci influencing lung cancer risk on chromosomes 6q and 12q. Cancer Epidemiol Biomarkers Prev. 2010 Dec; 19(12):3157-66.
    View in: PubMed
    Score: 0.030
  12. Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. J Natl Cancer Inst. 2010 Aug 04; 102(15):1199-205.
    View in: PubMed
    Score: 0.030
  13. Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res. 2010 Feb 15; 16(4):1331-9.
    View in: PubMed
    Score: 0.029
  14. Racial differences in the association between SNPs on 15q25.1, smoking behavior, and risk of non-small cell lung cancer. J Thorac Oncol. 2009 Oct; 4(10):1195-201.
    View in: PubMed
    Score: 0.028
  15. Seizure 6-like (SEZ6L) gene and risk for lung cancer. Cancer Res. 2007 Sep 01; 67(17):8406-11.
    View in: PubMed
    Score: 0.024
  16. Associations of genetic risk and modifiable lifestyle factors with comorbid psoriasis and Crohns disease. Clin Exp Dermatol. 2025 Oct 27; 50(11):2232-2239.
    View in: PubMed
    Score: 0.022
  17. Sensitivity to Environmental Stress and Adversity and Lung Cancer. JAMA Netw Open. 2025 01 02; 8(1):e2457079.
    View in: PubMed
    Score: 0.020
  18. Genomic insights for personalised care in lung cancer and smoking cessation: motivating at-risk individuals toward evidence-based health practices. EBioMedicine. 2024 Dec; 110:105441.
    View in: PubMed
    Score: 0.020
  19. Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosis. Hepatol Commun. 2024 Nov 01; 8(11).
    View in: PubMed
    Score: 0.020
  20. Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk. Nat Commun. 2024 10 04; 15(1):8629.
    View in: PubMed
    Score: 0.020
  21. Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions. Prog Cardiovasc Dis. 2024 Sep-Oct; 86:79-85.
    View in: PubMed
    Score: 0.020
  22. On the informative value of community-based indoor radon values in relation to lung cancer. Cancer Med. 2024 Aug; 13(16):e70126.
    View in: PubMed
    Score: 0.020
  23. PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk. Clin Gastroenterol Hepatol. 2024 Sep; 22(9):1858-1866.e4.
    View in: PubMed
    Score: 0.019
  24. Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers. Nat Commun. 2024 Apr 29; 15(1):3621.
    View in: PubMed
    Score: 0.019
  25. Thrombosis risk prediction in lymphoma patients: A multi-institutional, retrospective model development and validation study. Am J Hematol. 2024 07; 99(7):1230-1239.
    View in: PubMed
    Score: 0.019
  26. Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification. Genome Med. 2024 02 05; 16(1):22.
    View in: PubMed
    Score: 0.019
  27. Ethnic differences of genetic risk and smoking in lung cancer: two prospective cohort studies. Int J Epidemiol. 2023 12 25; 52(6):1815-1825.
    View in: PubMed
    Score: 0.019
  28. Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma. Cancer Epidemiol Biomarkers Prev. 2023 10 02; 32(10):1338-1347.
    View in: PubMed
    Score: 0.019
  29. Integrative Genetic Approach Facilitates Precision Strategies for Acute Myocardial Infarction. Genes (Basel). 2023 06 26; 14(7).
    View in: PubMed
    Score: 0.018
  30. Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions. J Natl Cancer Inst. 2023 06 08; 115(6):712-732.
    View in: PubMed
    Score: 0.018
  31. Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2023 12; 21(13):3296-3304.e3.
    View in: PubMed
    Score: 0.018
  32. Common genetic variations in telomere length genes and lung cancer: a Mendelian randomisation study and its novel application in lung tumour transcriptome. Elife. 2023 04 20; 12.
    View in: PubMed
    Score: 0.018
  33. Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score. PLoS One. 2023; 18(2):e0282309.
    View in: PubMed
    Score: 0.018
  34. Risk factors for HCC in contemporary cohorts of patients with cirrhosis. Hepatology. 2023 03 01; 77(3):997-1005.
    View in: PubMed
    Score: 0.018
  35. Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers. Mov Disord. 2023 04; 38(4):604-615.
    View in: PubMed
    Score: 0.018
  36. Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems. J Clin Oncol. 2023 06 01; 41(16):2926-2938.
    View in: PubMed
    Score: 0.018
  37. Clonal Hematopoiesis and Risk of Incident Lung Cancer. J Clin Oncol. 2023 03 01; 41(7):1423-1433.
    View in: PubMed
    Score: 0.018
  38. Disentangling the aetiological pathways between body mass index and site-specific cancer risk using tissue-partitioned Mendelian randomisation. Br J Cancer. 2023 02; 128(4):618-625.
    View in: PubMed
    Score: 0.018
  39. Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements. Cancer Epidemiol Biomarkers Prev. 2022 10 04; 31(10):1966-1974.
    View in: PubMed
    Score: 0.017
  40. Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations. Am J Hematol. 2022 08; 97(8):1044-1054.
    View in: PubMed
    Score: 0.017
  41. Genetic variants in CYP2B6 and HSD17B12 associated with risk of squamous cell carcinoma of the head and neck. Int J Cancer. 2022 08 15; 151(4):553-564.
    View in: PubMed
    Score: 0.017
  42. External validation of the HIGH-2-LOW model: A predictive score for venous thromboembolism after allogeneic transplant. Am J Hematol. 2022 06 01; 97(6):740-748.
    View in: PubMed
    Score: 0.017
  43. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis. PLoS Med. 2022 02; 19(2):e1003897.
    View in: PubMed
    Score: 0.017
  44. Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Med. 2022 01 11; 20(1):3.
    View in: PubMed
    Score: 0.017
  45. Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. Cancer Res. 2022 01 15; 82(2):199-209.
    View in: PubMed
    Score: 0.016
  46. Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer. Nat Commun. 2021 10 12; 12(1):5945.
    View in: PubMed
    Score: 0.016
  47. Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation. Am J Hematol. 2021 09 01; 96(9):1137-1146.
    View in: PubMed
    Score: 0.016
  48. Outcomes of Aortic Valve Replacement for Chronic Aortic Insufficiency: Analysis of the Society of Thoracic Surgeons Database. Ann Thorac Surg. 2022 03; 113(3):763-772.
    View in: PubMed
    Score: 0.016
  49. Two-Sample Mendelian Randomization Analysis of Associations Between Periodontal Disease and Risk of Cancer. JNCI Cancer Spectr. 2021 06; 5(3).
    View in: PubMed
    Score: 0.016
  50. The Shared Genetic Architectures Between Lung Cancer and Multiple Polygenic Phenotypes in Genome-Wide Association Studies. Cancer Epidemiol Biomarkers Prev. 2021 06; 30(6):1156-1164.
    View in: PubMed
    Score: 0.016
  51. Tobacco Smoking and Risk of Second Primary Lung Cancer. J Thorac Oncol. 2021 06; 16(6):968-979.
    View in: PubMed
    Score: 0.016
  52. Age-associated risk of cancer among individuals with N-acetyltransferase 2 (NAT2) mutations and mutations in DNA mismatch repair genes. Cancer Res. 2001 Feb 15; 61(4):1269-71.
    View in: PubMed
    Score: 0.016
  53. Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model. Cancer Res. 2021 03 15; 81(6):1607-1615.
    View in: PubMed
    Score: 0.015
  54. Physical Activity Does Not Lower the Risk of Lung Cancer. Cancer Res. 2020 09 01; 80(17):3765-3769.
    View in: PubMed
    Score: 0.015
  55. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nat Commun. 2020 07 03; 11(1):3353.
    View in: PubMed
    Score: 0.015
  56. Protein-altering germline mutations implicate novel genes related to lung cancer development. Nat Commun. 2020 05 11; 11(1):2220.
    View in: PubMed
    Score: 0.015
  57. Update on genetic risk factors for systemic lupus erythematosus and rheumatoid arthritis. Curr Opin Rheumatol. 2000 Mar; 12(2):85-90.
    View in: PubMed
    Score: 0.015
  58. Whole Exome Sequencing of Highly Aggregated Lung Cancer Families Reveals Linked Loci for Increased Cancer Risk on Chromosomes 12q, 7p, and 4q. Cancer Epidemiol Biomarkers Prev. 2020 02; 29(2):434-442.
    View in: PubMed
    Score: 0.014
  59. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. Lancet Respir Med. 2019 10; 7(10):881-891.
    View in: PubMed
    Score: 0.014
  60. Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer. Cancer Epidemiol Biomarkers Prev. 2019 07; 28(7):1228-1237.
    View in: PubMed
    Score: 0.014
  61. Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region. J Thorac Oncol. 2019 08; 14(8):1360-1369.
    View in: PubMed
    Score: 0.014
  62. Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans. Cancer Epidemiol Biomarkers Prev. 2019 04; 28(4):715-723.
    View in: PubMed
    Score: 0.014
  63. Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis. Cancer Epidemiol Biomarkers Prev. 2019 05; 28(5):935-942.
    View in: PubMed
    Score: 0.013
  64. Is there a genetic basis for lung cancer susceptibility? Recent Results Cancer Res. 1999; 151:3-12.
    View in: PubMed
    Score: 0.013
  65. Sex-specific gene and pathway modeling of inherited glioma risk. Neuro Oncol. 2019 01 01; 21(1):71-82.
    View in: PubMed
    Score: 0.013
  66. Smoking and Other Risk Factors in Individuals With Synchronous Conventional High-Risk Adenomas and Clinically Significant Serrated Polyps. Am J Gastroenterol. 2018 12; 113(12):1828-1835.
    View in: PubMed
    Score: 0.013
  67. Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nat Commun. 2018 08 13; 9(1):3221.
    View in: PubMed
    Score: 0.013
  68. Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer. J Thorac Oncol. 2018 10; 13(10):1483-1495.
    View in: PubMed
    Score: 0.013
  69. Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners. Int Arch Occup Environ Health. 2018 Nov; 91(8):937-950.
    View in: PubMed
    Score: 0.013
  70. Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21. Sci Rep. 2018 05 09; 8(1):7352.
    View in: PubMed
    Score: 0.013
  71. Cigarette smoking in a multiethnic population of youth: methods and baseline findings. Prev Med. 1998 May-Jun; 27(3):365-84.
    View in: PubMed
    Score: 0.013
  72. Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk. J Invest Dermatol. 2018 09; 138(9):2072-2075.
    View in: PubMed
    Score: 0.013
  73. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat Genet. 2017 Dec; 49(12):1767-1778.
    View in: PubMed
    Score: 0.012
  74. Estimating the strength of genetic effects: a comparison of maximum likelihood and transmission disequilibrium methods in the study of ankylosing spondylitis. Hum Immunol. 1997 Sep 15; 57(1):44-50.
    View in: PubMed
    Score: 0.012
  75. Quantifying the Genetic Correlation between Multiple Cancer Types. Cancer Epidemiol Biomarkers Prev. 2017 09; 26(9):1427-1435.
    View in: PubMed
    Score: 0.012
  76. Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study. PLoS One. 2017; 12(6):e0177875.
    View in: PubMed
    Score: 0.012
  77. Functional variants in DCAF4 associated with lung cancer risk in European populations. Carcinogenesis. 2017 05 01; 38(5):541-551.
    View in: PubMed
    Score: 0.012
  78. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat Genet. 2017 May; 49(5):680-691.
    View in: PubMed
    Score: 0.012
  79. Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Sci Rep. 2017 03 17; 7:44634.
    View in: PubMed
    Score: 0.012
  80. A Novel Genetic Variant in Long Non-coding RNA Gene NEXN-AS1 is Associated with Risk of Lung Cancer. Sci Rep. 2016 10 07; 6:34234.
    View in: PubMed
    Score: 0.011
  81. Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses. PLoS Med. 2016 Sep; 13(9):e1002118.
    View in: PubMed
    Score: 0.011
  82. Pleiotropic Analysis of Lung Cancer and Blood Triglycerides. J Natl Cancer Inst. 2016 12; 108(12).
    View in: PubMed
    Score: 0.011
  83. Melanoma Expression Genes Identified through Genome-Wide Association Study of?Breslow Tumor Thickness. J Invest Dermatol. 2017 01; 137(1):253-257.
    View in: PubMed
    Score: 0.011
  84. The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization study. Sci Rep. 2016 08 04; 6:31121.
    View in: PubMed
    Score: 0.011
  85. Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer. Int J Epidemiol. 2016 06; 45(3):896-908.
    View in: PubMed
    Score: 0.011
  86. Assessing genetic linkage and association with robust components of variance approaches. Ann Hum Genet. 1996 03; 60(2):143-60.
    View in: PubMed
    Score: 0.011
  87. Polymorphisms of the centrosomal gene (FGFR1OP) and lung cancer risk: a meta-analysis of 14,463 cases and 44,188 controls. Carcinogenesis. 2016 Mar; 37(3):280-289.
    View in: PubMed
    Score: 0.011
  88. Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):282-90.
    View in: PubMed
    Score: 0.011
  89. The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium. Am J Epidemiol. 2016 Jan 15; 183(2):85-91.
    View in: PubMed
    Score: 0.011
  90. A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2016 Jan; 25(1):193-200.
    View in: PubMed
    Score: 0.011
  91. Component-wise gradient boosting and false discovery control in survival analysis with high-dimensional covariates. Bioinformatics. 2016 Jan 01; 32(1):50-7.
    View in: PubMed
    Score: 0.011
  92. Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups. Ann Rheum Dis. 2016 Aug; 75(8):1558-66.
    View in: PubMed
    Score: 0.011
  93. Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes. Genes Immun. 2015 Oct; 16(7):470-80.
    View in: PubMed
    Score: 0.011
  94. TERT Polymorphism rs2736100-C Is Associated with EGFR Mutation-Positive Non-Small Cell Lung Cancer. Clin Cancer Res. 2015 Nov 15; 21(22):5173-5180.
    View in: PubMed
    Score: 0.011
  95. Low-frequency coding variants at 6p21.33 and 20q11.21 are associated with lung cancer risk in Chinese populations. Am J Hum Genet. 2015 May 07; 96(5):832-40.
    View in: PubMed
    Score: 0.010
  96. CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. J Natl Cancer Inst. 2015 May; 107(5).
    View in: PubMed
    Score: 0.010
  97. Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 2015 Jul; 149(1):119-29.
    View in: PubMed
    Score: 0.010
  98. Community-wide cardiovascular disease prevention programs and health outcomes in a rural county, 1970-2010. JAMA. 2015 Jan 13; 313(2):147-55.
    View in: PubMed
    Score: 0.010
  99. Identification of a melanoma susceptibility locus and somatic mutation in TET2. Carcinogenesis. 2014 Sep; 35(9):2097-101.
    View in: PubMed
    Score: 0.010
  100. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2014 Jul; 46(7):736-41.
    View in: PubMed
    Score: 0.010
  101. Pleiotropic associations of risk variants identified for other cancers with lung cancer risk: the PAGE and TRICL consortia. J Natl Cancer Inst. 2014 Apr; 106(4):dju061.
    View in: PubMed
    Score: 0.010
  102. A network-based kernel machine test for the identification of risk pathways in genome-wide association studies. Hum Hered. 2013; 76(2):64-75.
    View in: PubMed
    Score: 0.010
  103. Health-Related Quality of Life (HRQoL) in alopecia areata patients-a secondary analysis of the National Alopecia Areata Registry Data. J Investig Dermatol Symp Proc. 2013 Dec; 16(1):S49-50.
    View in: PubMed
    Score: 0.009
  104. Genes-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Cancer Epidemiol Biomarkers Prev. 2014 Jan; 23(1):98-106.
    View in: PubMed
    Score: 0.009
  105. Pilot study of CYP2B6 genetic variation to explore the contribution of nitrosamine activation to lung carcinogenesis. Int J Mol Sci. 2013 Apr 16; 14(4):8381-92.
    View in: PubMed
    Score: 0.009
  106. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control. 2013 Jun; 24(6):1207-22.
    View in: PubMed
    Score: 0.009
  107. Obesity-related genetic variants, human pigmentation, and risk of melanoma. Hum Genet. 2013 Jul; 132(7):793-801.
    View in: PubMed
    Score: 0.009
  108. Association between putative functional variants in the PSMB9 gene and risk of melanoma--re-analysis of published melanoma genome-wide association studies. Pigment Cell Melanoma Res. 2013 May; 26(3):392-401.
    View in: PubMed
    Score: 0.009
  109. A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet. 2013 Apr; 45(4):428-32, 432e1.
    View in: PubMed
    Score: 0.009
  110. Variants in melanocortin 1 receptor gene contribute to risk of melanoma--a direct sequencing analysis in a Texas population. Pigment Cell Melanoma Res. 2013 May; 26(3):422-5.
    View in: PubMed
    Score: 0.009
  111. Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in han chinese. PLoS Genet. 2013; 9(1):e1003190.
    View in: PubMed
    Score: 0.009
  112. Genetic epidemiology of epithelial ovarian cancer. Cancer. 1993 Jan 15; 71(2 Suppl):566-72.
    View in: PubMed
    Score: 0.009
  113. On the interplay of telomeres, nevi and the risk of melanoma. PLoS One. 2012; 7(12):e52466.
    View in: PubMed
    Score: 0.009
  114. Cell cycle-related genes as modifiers of age of onset of colorectal cancer in Lynch syndrome: a large-scale study in non-Hispanic white patients. Carcinogenesis. 2013 Feb; 34(2):299-306.
    View in: PubMed
    Score: 0.009
  115. Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans. Oncotarget. 2012 Nov; 3(11):1428-38.
    View in: PubMed
    Score: 0.009
  116. Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer. Cancer Res. 2013 Jan 01; 73(1):256-64.
    View in: PubMed
    Score: 0.009
  117. Method for evaluating multiple mediators: mediating effects of smoking and COPD on the association between the CHRNA5-A3 variant and lung cancer risk. PLoS One. 2012; 7(10):e47705.
    View in: PubMed
    Score: 0.009
  118. Age at onset for familial epithelial ovarian cancer. JAMA. 1992 Oct 14; 268(14):1896-9.
    View in: PubMed
    Score: 0.009
  119. Host factors in lung cancer risk: a review of interdisciplinary studies. Cancer Epidemiol Biomarkers Prev. 1992 Sep-Oct; 1(6):505-13.
    View in: PubMed
    Score: 0.009
  120. Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. Genes Immun. 2012 Sep; 13(6):461-8.
    View in: PubMed
    Score: 0.008
  121. Comparison of pathway analysis approaches using lung cancer GWAS data sets. PLoS One. 2012; 7(2):e31816.
    View in: PubMed
    Score: 0.008
  122. Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO. Breast Cancer Res Treat. 2012 May; 133(1):347-55.
    View in: PubMed
    Score: 0.008
  123. Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes. Genes Immun. 2012 Jun; 13(4):328-35.
    View in: PubMed
    Score: 0.008
  124. Exonuclease 1 (EXO1) gene variation and melanoma risk. DNA Repair (Amst). 2012 Mar 01; 11(3):304-9.
    View in: PubMed
    Score: 0.008
  125. Genetic determinants for promoter hypermethylation in the lungs of smokers: a candidate gene-based study. Cancer Res. 2012 Feb 01; 72(3):707-15.
    View in: PubMed
    Score: 0.008
  126. No association between Parkinson disease alleles and the risk of melanoma. Cancer Epidemiol Biomarkers Prev. 2012 Jan; 21(1):243-5.
    View in: PubMed
    Score: 0.008
  127. Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. Cancer Discov. 2011 Oct; 1(5):420-9.
    View in: PubMed
    Score: 0.008
  128. Susceptibility locus for lung cancer at 15q25.1 is not associated with risk of pancreatic cancer. Pancreas. 2011 Aug; 40(6):872-5.
    View in: PubMed
    Score: 0.008
  129. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. J Natl Cancer Inst. 2011 Sep 07; 103(17):1342-6.
    View in: PubMed
    Score: 0.008
  130. Sex-specific effect of the TP53 PIN3 polymorphism on cancer risk in a cohort study of TP53 germline mutation carriers. Hum Genet. 2011 Dec; 130(6):789-94.
    View in: PubMed
    Score: 0.008
  131. Association of smoking with tumor size at diagnosis in non-small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):378-83.
    View in: PubMed
    Score: 0.008
  132. Familiality of breast cancer and socioeconomic status in blacks. Cancer Res. 1991 Apr 01; 51(7):1793-7.
    View in: PubMed
    Score: 0.008
  133. Segregation analysis of breast cancer from the cancer and steroid hormone study: histologic subtypes. J Natl Cancer Inst. 1990 Dec 19; 82(24):1911-7.
    View in: PubMed
    Score: 0.008
  134. Admixture mapping of lung cancer in 1812 African-Americans. Carcinogenesis. 2011 Mar; 32(3):312-7.
    View in: PubMed
    Score: 0.008
  135. Interactions between cigarette smoking and selected polymorphisms in xenobiotic metabolizing enzymes in risk for colorectal cancer: A case-only analysis. Mol Carcinog. 2010 Nov; 49(11):974-80.
    View in: PubMed
    Score: 0.008
  136. A multivariate method for detecting genetic linkage, with application to a pedigree with an adverse lipoprotein phenotype. Am J Hum Genet. 1990 Aug; 47(2):247-54.
    View in: PubMed
    Score: 0.007
  137. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet. 2010 Aug; 42(8):655-7.
    View in: PubMed
    Score: 0.007
  138. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst. 2010 Jul 07; 102(13):959-71.
    View in: PubMed
    Score: 0.007
  139. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010 Jun; 42(6):508-14.
    View in: PubMed
    Score: 0.007
  140. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet. 2010 May; 42(5):426-9.
    View in: PubMed
    Score: 0.007
  141. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010 Jan 15; 16(2):764-74.
    View in: PubMed
    Score: 0.007
  142. Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study. Pancreas. 2010 Jan; 39(1):1-4.
    View in: PubMed
    Score: 0.007
  143. Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst. 2009 Dec 16; 101(24):1731-2; author reply 1732.
    View in: PubMed
    Score: 0.007
  144. Health and lifestyle behaviors among persons at risk of Lynch syndrome. Cancer Causes Control. 2010 Apr; 21(4):513-21.
    View in: PubMed
    Score: 0.007
  145. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet. 2009 Dec; 41(12):1313-8.
    View in: PubMed
    Score: 0.007
  146. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet. 2009 11; 85(5):679-91.
    View in: PubMed
    Score: 0.007
  147. Polymorphism in the 5'-flanking region of the insulin gene and its potential relation to cardiovascular disease risk: observations in a biracial community. The Bogalusa Heart Study. Atherosclerosis. 1989 Sep; 79(1):51-7.
    View in: PubMed
    Score: 0.007
  148. Genetic variants in IL-23R and ATG16L1 independently predispose to increased susceptibility to Crohn's disease in a Canadian population. J Clin Gastroenterol. 2009 May-Jun; 43(5):444-7.
    View in: PubMed
    Score: 0.007
  149. CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population. Arthritis Rheum. 2009 Apr; 60(4):931-7.
    View in: PubMed
    Score: 0.007
  150. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst. 2008 Nov 05; 100(21):1552-6.
    View in: PubMed
    Score: 0.007
  151. Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst. 2008 Aug 06; 100(15):1104-12.
    View in: PubMed
    Score: 0.007
  152. Trends in prevalence of prognostic factors and survival in lung cancer patients from 1985 to 2004 at a tertiary care center. Cancer Detect Prev. 2008; 32(2):101-8.
    View in: PubMed
    Score: 0.006
  153. A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2. PLoS Genet. 2008 Jun 27; 4(6):e1000107.
    View in: PubMed
    Score: 0.006
  154. DNA repair capacity and lung cancer risk in never smokers. Cancer Epidemiol Biomarkers Prev. 2008 Jun; 17(6):1322-8.
    View in: PubMed
    Score: 0.006
  155. Building a predictive breast cancer risk model. AMIA Annu Symp Proc. 2007 Oct 11; 995.
    View in: PubMed
    Score: 0.006
  156. TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. N Engl J Med. 2007 Sep 20; 357(12):1199-209.
    View in: PubMed
    Score: 0.006
  157. Aggregation of cancer among relatives of never-smoking lung cancer patients. Int J Cancer. 2007 Jul 01; 121(1):111-8.
    View in: PubMed
    Score: 0.006
  158. Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk. Int J Cancer. 2007 Jun 15; 120(12):2687-95.
    View in: PubMed
    Score: 0.006
  159. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study. Cancer. 2006 Dec 15; 107(12):2745-51.
    View in: PubMed
    Score: 0.006
  160. Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis Rheum. 2006 Dec; 54(12):3820-7.
    View in: PubMed
    Score: 0.006
  161. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2006 Sep 15; 12(18):5596-602.
    View in: PubMed
    Score: 0.006
  162. Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome. Cancer Res. 2006 Aug 15; 66(16):8287-92.
    View in: PubMed
    Score: 0.006
  163. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol Biomarkers Prev. 2006 May; 15(5):886-91.
    View in: PubMed
    Score: 0.006
  164. Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer. 2006 Apr 01; 118(7):1798-804.
    View in: PubMed
    Score: 0.006
  165. DLG5 variants contribute to Crohn disease risk in a Canadian population. Hum Mutat. 2006 Apr; 27(4):353-8.
    View in: PubMed
    Score: 0.006
  166. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006 Mar; 78(3):464-79.
    View in: PubMed
    Score: 0.005
  167. IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst. 2006 Jan 18; 98(2):139-43.
    View in: PubMed
    Score: 0.005
  168. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst. 2005 Dec 21; 97(24):1822-31.
    View in: PubMed
    Score: 0.005
  169. Support for previously identified alcoholism susceptibility Loci in a cohort selected for smoking behavior. Alcohol Clin Exp Res. 2005 Dec; 29(12):2108-15.
    View in: PubMed
    Score: 0.005
  170. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum. 2005 Nov; 52(11):3433-8.
    View in: PubMed
    Score: 0.005
  171. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet. 2005 Oct; 77(4):567-81.
    View in: PubMed
    Score: 0.005
  172. Relationship between plasma carotenoids and prostate cancer. Nutr Cancer. 2005; 53(2):127-34.
    View in: PubMed
    Score: 0.005
  173. p73 G4C14-to-A4T14 polymorphism and risk of lung cancer. Cancer Res. 2004 Oct 01; 64(19):6863-6.
    View in: PubMed
    Score: 0.005
  174. p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Clin Cancer Res. 2004 Sep 01; 10(17):5845-9.
    View in: PubMed
    Score: 0.005
  175. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2004 Oct; 25(10):1911-6.
    View in: PubMed
    Score: 0.005
  176. An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology. Cancer Res. 2004 Mar 15; 64(6):2251-7.
    View in: PubMed
    Score: 0.005
  177. Risk for smoking-related cancer among relatives of lung cancer patients. Cancer Res. 2003 Dec 01; 63(23):8531-5.
    View in: PubMed
    Score: 0.005
  178. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer. 2003 Oct 20; 107(1):84-8.
    View in: PubMed
    Score: 0.005
  179. Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10):980-6.
    View in: PubMed
    Score: 0.005
  180. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003 Aug 20; 95(16):1211-8.
    View in: PubMed
    Score: 0.005
  181. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev. 2003 Aug; 12(8):689-98.
    View in: PubMed
    Score: 0.005
  182. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk. Hum Genet. 2003 Aug; 113(3):238-43.
    View in: PubMed
    Score: 0.005
  183. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis. 2003 Mar; 24(3):505-9.
    View in: PubMed
    Score: 0.004
  184. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet. 2003 Apr; 72(4):975-83.
    View in: PubMed
    Score: 0.004
  185. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst. 2003 Feb 19; 95(4):308-15.
    View in: PubMed
    Score: 0.004
  186. Genetic susceptibility for lung cancer: interactions with gender and smoking history and impact on early detection policies. Hum Hered. 2003; 56(1-3):139-45.
    View in: PubMed
    Score: 0.004
  187. Power of a simplified multivariate test for genetic linkage. Ann Hum Genet. 2002 Nov; 66(Pt 5-6):407-17.
    View in: PubMed
    Score: 0.004
  188. Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice. Hum Mol Genet. 2002 Aug 01; 11(16):1855-63.
    View in: PubMed
    Score: 0.004
  189. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. J Natl Cancer Inst. 2002 May 01; 94(9):681-90.
    View in: PubMed
    Score: 0.004
  190. Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients. Br J Cancer. 2001 Sep 28; 85(7):1037-46.
    View in: PubMed
    Score: 0.004
  191. Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst. 2001 Jul 18; 93(14):1106-8.
    View in: PubMed
    Score: 0.004
  192. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1017-20.
    View in: PubMed
    Score: 0.004
  193. Epidemiologic determinants of clinically relevant prostate cancer. Int J Cancer. 2000 May 20; 89(3):259-64.
    View in: PubMed
    Score: 0.004
  194. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J Natl Cancer Inst. 2000 May 03; 92(9):737-43.
    View in: PubMed
    Score: 0.004
  195. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. Growth Horm IGF Res. 2000 Apr; 10 Suppl A:S26-7.
    View in: PubMed
    Score: 0.004
  196. Segregation analysis of squamous cell carcinoma of the head and neck: evidence for a major gene determining risk. Ann Hum Genet. 1998 Nov; 62(Pt 6):505-10.
    View in: PubMed
    Score: 0.003
  197. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation. 1998 May 12; 97(18):1773-9.
    View in: PubMed
    Score: 0.003
  198. Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk. Carcinogenesis. 1998 Jan; 19(1):93-8.
    View in: PubMed
    Score: 0.003
  199. Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychol. 1997 Jan; 16(1):73-86.
    View in: PubMed
    Score: 0.003
  200. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis. 1995 Sep; 16(9):2205-8.
    View in: PubMed
    Score: 0.003
  201. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins. J Pediatr. 1995 Apr; 126(4):625-32.
    View in: PubMed
    Score: 0.003
  202. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev. 1995 Mar; 4(2):99-103.
    View in: PubMed
    Score: 0.003
  203. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst. 1994 Nov 16; 86(22):1681-4.
    View in: PubMed
    Score: 0.003
  204. Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. Arthritis Rheum. 1994 Aug; 37(8):1212-20.
    View in: PubMed
    Score: 0.002
  205. High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet. 1991 Dec 14; 338(8781):1471-5.
    View in: PubMed
    Score: 0.002
  206. Cigarette smoking, alcohol, and oral contraceptive use by type A adolescent--the Bogalusa Heart Study. J Behav Med. 1989 Feb; 12(1):13-24.
    View in: PubMed
    Score: 0.002
  207. Association between polymorphic blood markers and risk factors for cardiovascular disease in a large pedigree. Genet Epidemiol. 1987; 4(4):267-75.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.